Clinical protocol for the use of biologic therapy in COPD - PubMed
4 hours ago
- #Biologics
- #COPD
- #Precision Medicine
- Preventing exacerbations in COPD is a priority due to their impact on disease progression, mortality, and quality of life.
- Biologic therapies, such as monoclonal antibodies, offer a precision medicine approach for high-risk COPD patients with frequent exacerbations despite optimal inhaled treatment.
- The use of biologics in COPD is challenging due to clinical heterogeneity and limited evidence, requiring personalized and precise management.
- This protocol outlines objectives, candidate selection, response monitoring, and implementation strategies for biologic therapy in COPD based on evidence and expert consensus.